Analysis Moderna’s Pipeline Widens Beyond Melanoma, but Each Study Stands on Its Own
Moderna’s cancer vaccine programme now stretches into pancreatic cancer, yet the fresh Phase I data presented at ESMO do nothing to settle the larger question hanging over the stock: how...